Neurodegenerative disease is a group of diseases or conditions that affect the neurons in the human brain. Inability of neurons to reproduce themselves contributes to the progression of neurodegenerative diseases. Hence, death of neurons indicates permanent loss which cannot be replaced. Neurodegenerative diseases include Alzheimer’s, Parkinson’s, and Huntington’s. These diseases are also considered to be genetic. For instance, research studies indicate that over 5% of Alzheimer’s disease is caused by transfer of dominant genes in families. Similarly, Huntington’s disease follows an autosomal dominant pattern of inheritance. However, the exact cause of these diseases is still unclear.    

Dementia represents the initial stage of neurodegenerative diseases. Alzheimer’s accounts for over 65% of the dementia cases globally. According to the National Institute of Environmental Health Sciences, Alzheimer’s and Parkinson’s are the common types of neurodegenerative diseases. Over five million people are affected by Alzheimer’s and  more than 500,000 people are affected by Parkinson’s in the U.S. Rise in prevalence of these diseases, increase in geriatric population, focus on research & development of novel treatment methods, and strong pipeline are anticipated to contribute to the growth of the market. Additionally, growing focus on the development of stem cell technologies for the treatment of the neurodegenerative disorders is expected to drive the market. However, continuous progression of the diseases, high cost of treatment, complexity of these diseases, lack of knowledge about the cost of the diseases, and low disposable income in certain regions are projected to hamper the growth of the market.

The neurodegenerative disease treatment market can be segmented based on treatment type, indication, and region. Based on treatment type, the market can be bifurcated into drug class and stem cell therapy. The drug class segment can be sub-segmented into dopaminergic compounds, cholinesterase inhibitors, antipsychotic drugs, non-steroidal anti-inflammatory drugs, selective serotonin reuptake inhibitors (SSRIs), and others. In terms of indication, the market can be segmented into Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, amyotrophic lateral sclerosis, and others. Alzheimer’s disease is anticipated to be the dominant segment during the forecast period owing to increasing prevalence of the disease.

Geographically, the neurodegenerative disease treatment market can be segmented into five regions: North America, Europe, Latin America, Asia Pacific, and Middle East & Africa. North America was the dominant market in terms of revenues in 2016. It is anticipated to continue its dominance during the forecast period. Growth of the market in the region can be attributed to well-established health care infrastructure in the region, growing awareness among the people about the available treatment modes, and strong focus on research & development of novel therapies to treat neurodegenerative diseases. Europe is anticipated to be the second largest market in terms of revenue and grow at slow rate in the forecast period. Slow growth in the region can be attributed to its sluggish economic recovery. The market in Asia Pacific is anticipated to expand at a significantly high CAGR during the forecast period driven by India and China. Growth in these countries can be attributed to the rise in the geriatric population that would expanding the patient pool and government focus on improving health care facilities.

Leading players in the neurodegenerative disease treatment market include Bayer AG, Biogen, GlaxoSmithKline plc, Boehringer Ingelheim, Pfizer, Inc., Sanofi S.A., Merck KGaA, Novartis AG, Teva Pharmaceutical Industries Ltd., and QR Pharma, Inc., among others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Neurodegenerative Disease Treatment Market

Pre Book